#SlateMedicines
Funding Raises: #Castelion $1B Series C; #Higgsfield $400M Series B; #Groq $350M Series A; #WisprFlow $280M Series B; #MuonSpace $250M Series C; #GravisRobotics $200M Series A

Acquisitions: #BKL > #DaleEvans; #Checkr > #Truv; #SpaceX > #Cursor

Merger: #SlateMedicines & #FulcrumTherapeutics
August 21, 2026 at 4:39 PM
#Blooddisorder specialist #FulcrumTherapeutics has agreed to what amounts to a #reversemerger with #SlateMedicines, a privately held #biotech focused on next generation therapies for #migraine.

pharmaphorum.com/news/after-f...
After failure in sickle cell, Fulcrum merges with Slate
Following the failure of its sickle cell programme, Fulcrum Therapeutics will merge with Slate Medicines to advance Slate's migraine therapy.
pharmaphorum.com
August 18, 2026 at 9:31 AM
Funding Raises: #MatX $500M Series B; #VeroNetworks $500M Growth Equity; #SambaNova +$350M Series E; #AlveusTherapeutics $197M Series A ext.; #AllicaBank $155M Series D; #Revel $150M Series B; #HonetHealth $140M;
#SlateMedicines $130M Series A; #CodeMetal $125M Series B
February 27, 2026 at 9:23 PM